The 2001 Bethesda System: terminology for reporting results of cervical cytology

Author(s): Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, et al.

Abstract

Objectives: The Bethesda 2001 Workshop was convened to evaluate and update the 1991 Bethesda System terminology for reporting the results of cervical cytology. A primary objective was to develop a new approach to broaden participation in the consensus process.

Participants: Forum groups composed of 6 to 10 individuals were responsible for developing recommendations for discussion at the workshop. Each forum group included at least 1 cytopathologist, cytotechnologist, clinician, and international representative to ensure a broad range of views and interests. More than 400 cytopathologists, cytotechnologists, histopathologists, family practitioners, gynecologists, public health physicians, epidemiologists, patient advocates, and attorneys participated in the workshop, which was convened by the National Cancer Institute and cosponsored by 44 professional societies. More than 20 countries were represented.

Evidence: Literature review, expert opinion, and input from an Internet bulletin board were all considered in developing recommendations. The strength of evidence of the scientific data was considered of paramount importance.

Consensus process: Bethesda 2001 was a year-long iterative review process. An Internet bulletin board was used for discussion of issues and drafts of recommendations. More than 1000 comments were posted to the bulletin board over the course of 6 months. The Bethesda Workshop, held April 30-May 2, 2001, was open to the public. Postworkshop recommendations were posted on the bulletin board for a last round of critical review prior to finalizing the terminology.

Conclusions: Bethesda 2001 was developed with broad participation in the consensus process. The 2001 Bethesda System terminology reflects important advances in biological understanding of cervical neoplasia and cervical screening technology.

Similar Articles

Comparison of non-invasive sampling methods for detection of HPV in rural African women

Author(s): Lack N, West B, Jeffries D, Ekpo G, Morison L, et al.

Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination

Author(s): Mollers M, Scherpenisse M, van der Klis FR, King AJ, van Rossum TG, et al.

A review of human carcinogens--Part B: biological agents

Author(s): Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, et al.

Self-sampling versus physician-sampling for human papillomavirus testing

Author(s): Agorastos T, Dinas K, Lloveras B, Font R, Kornegay JR, et al.

Comparison of type-specific human papillomavirus data from self and clinician directed sampling

Author(s): Baldwin S, Santos C, Mendez Brown E, Nuño T, Giuliano A, et al.

A comparison of cervical and vaginal human papillomavirus

Author(s): Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, et al.

Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women

Author(s): De Alba I, Anton-Culver H, Hubbell FA, Ziogas A, Hess JR, et al.

Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities

Author(s): Igidbashian S, Boveri S, Spolti N, Radice D, Sandri MT, et al.

ACOG Committee Opinion No

Author(s): American College of Obstetricians and Gynecologists